Clinical Trials Logo

Advanced Prostate Adenocarcinoma clinical trials

View clinical trials related to Advanced Prostate Adenocarcinoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04914195 Completed - Clinical trials for Advanced Prostate Adenocarcinoma

Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer

Start date: July 1, 2021
Phase: Phase 3
Study type: Interventional

This is a Randomized, Active Controlled, Comparative, Open-Label, Multi-Center, Phase 3 clinical study to compare the efficacy, safety, and pharmacokinetics of leuprolide acetate for injection 3.75mg (depot) of two brands (Luprodex and Lucrin) administered in subjects with advanced adenocarcinoma of the prostate. Approximately 168 subjects (males )of age above 18 years fulfilling the eligibility criteria will be enrolled. The IP will be given as a monthly dose for two cycles on day 0 and day 28. The pharmacokinetic analysis will be done for 12 patients receiving Luprodex. The primary and secondary outcomes will be captured on days as per protocol. Adverse events will be noted for safety evaluation.

NCT ID: NCT00502164 Completed - Clinical trials for Advanced Prostate Adenocarcinoma

Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer

AZD2171IL/0003
Start date: March 2004
Phase: Phase 1
Study type: Interventional

A study to assess safety and tolerability of AZD2171 after multiple doses in patients with advanced prostate cancer.